Healthcare + AI: AI Gets Empathic, How AI is Revolutionizing Clinical Trials, Pfizer Bets Big on Healthcare Innovation

At Healthcare + AI, we explore the latest trends and insights in healthcare and AI. Everything you need. Nothing you don’t. Find more on our site.

Today’s Features:

• AI Gets Empathic: Balancing Tech and Human Touch

• DDoS Attacks Soar in Healthcare with AI Use Rising

• AI Ethics in Medicine Get a Closer Look

• How AI is Revolutionizing Clinical Trials

• Pfizer Bets Big on Healthcare Innovation

AI Gets Empathic: Balancing Tech and Human Touch

The intersection of AI and healthcare is reshaping patient care. With telemedicine and AI-driven diagnostics on the rise, the balance between technology and empathy in healthcare has never been more crucial. Doctors now use AI not only to read MRI scans but also to ensure patients receive the human connection they need.

- 70% of healthcare leaders say they plan to invest in AI technologies over the next three years.

- AI-powered diagnostics can improve accuracy by up to 30%.

- Telemedicine adoption has increased by 40% since the onset of the pandemic.

Why It Matters: Balancing technology with empathy is key to ensuring patient trust and successful outcomes in an increasingly digital healthcare landscape.

What's Next: Healthcare providers will need to invest in training to help practitioners integrate AI tools while maintaining a personal touch. As AI tools evolve, the focus will be on finding ways to enhance rather than replace the human elements of patient care. Read More

Start the new year feeling refreshed and energized.

Cornbread Hemp’s CBD Sleep Gummies are here to help you achieve your best sleep yet. Unlike other options, these gummies are USDA organic and melatonin-free. Instead of melatonin, which can leave you groggy, they’re crafted with hemp flower, lavender, chamomile, and valerian root—ingredients that gently calm your mind and promote uninterrupted, restorative sleep.

As a Healthcare + AI reader, you’re in luck: use code RESOLUTION at checkout to enjoy 30% off your first order.*

Order now and wake up to better mornings.

*One-time purchases only, cannot be combined with subscription discounts.

DDoS Attacks Soar in Healthcare Alongside Rising AI Use

DDoS attacks are exploding, up by 82%, thanks to IoT devices and AI advances. The surge in attack rates has brought these malicious activities to the forefront, affecting sectors like healthcare significantly. Over 19,000 attacks were reported, mostly in the latter half of 2024.

By the Numbers:

- 82% increase in DDoS attacks.

- 11% of all incidents linked to these attacks.

- 19,000+ attacks recorded.

What They're Saying: "We're seeing attackers use larger botnets of compromised IoT devices and AI to drastically increase the scale of attacks. As the sophistication of DDoS attacks continues to grow, cybercriminals are finding ways to exploit cloud services, higher bandwidth availability, and new vulnerabilities in software and network protocols. Both the public and private sector need to invest heavily in DDoS mitigation to continue to protect critical infrastructure and ensure long-term data security." - Max Clauson, Senior Vice President of Network Connectivity at Zayo

Why It Matters: With healthcare's increased dependency on connected devices, these attacks pose serious risks to patient safety and data integrity.

What's Next: Expect a ramp-up in cyber defenses across vulnerable sectors like healthcare. Organizations will need to prioritize robust security measures to combat these growing threats. Read More

AI Ethics in Medicine Get a Closer Look

AI in healthcare is taking center stage as questions around ethics and regulation grow louder. The latest chatter comes from a deep dive into how medical ethics principles like autonomy and beneficence are being applied to AI-driven medical software.

- 70% of healthcare organizations are reportedly integrating AI tools in some form.

- 90% of AI applications in healthcare are expected to require regulatory oversight by 2025.

- $20 billion is projected to be invested in AI healthcare solutions by 2025.

From the Report: “With the rapid ongoing digital transformation of every field of life, the integration of artificial intelligence (AI) in medicine brings forth a whole new set of ethical challenges that need to be addressed. Although this confluence of two highly advanced disciplines has the potential to revolutionize medical practice and enhance the efficiency of healthcare systems, it has also raised ethical concerns regarding the use of AI-based devices in clinical settings. Explainability and transparency of AI algorithms are the characteristics that are crucial to ensuring the trust and accountability of these systems. Ethical frameworks are often taken as guiding principles to assess the ethical challenges associated with AI in medicine [6], but a more structured regulatory framework integrating the ethical component is essential to ensure patient safety.”

Why It Matters: AI holds the power to revolutionize healthcare, but ethical fog can cloud its potential, risking patient trust and safety.

What's Next: Expect increased pressure on policymakers to craft regulations that balance innovation with patient protection. As AI tech advances, look for more collaborations between ethicists, developers, and healthcare providers to navigate these uncharted waters. Read More

AI is Revolutionizing Clinical Trials

AI is shaking up the world of clinical trials, paving the way for groundbreaking changes in healthcare outcomes. The integration of AI technologies is streamlining processes, enhancing precision, and offering new insights into patient data.

By the Numbers:

- 30% reduction in trial completion time with AI integration.

- 25% increase in data accuracy due to advanced analytics.

- $10 billion projected savings in trial costs over the next five years.

Why It Matters: The use of AI in clinical trials not only speeds up the development of treatments but also ensures higher accuracy and efficiency, ultimately improving patient care.

What's Next: Expect more healthcare companies to adopt AI technologies in their trial processes. This shift will likely lead to faster drug approvals and more personalized medicine approaches. Read More

Pfizer Bets Big on Healthcare Innovation

Pharmaceutical giant Pfizer is stepping up its game in healthcare innovation, leveraging generative AI to spot illness patterns, potentially revolutionizing patient care. As part of this push, the company has extended is AI drug discovery partnership with PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery. The parties will launch a new Antibody-Drug-Conjugate (ADC) collaboration while also expanding their existing $260M AI Lab collaboration.

- Pfizer's R&D spending hit $10 billion last year.

- The company holds over 170 AI-related patents.

- Pfizer's stock is trading at a P/E ratio of 10.5, below the industry average.

What They’re Saying: "We're pleased to significantly expand the use of PostEra's Proton platform. This builds on peer-reviewed publications with Pfizer validating the real-world impact of AI-driven drug discovery in hitting preclinical milestones faster than anticipated. — Alpha Lee, Chief Scientific Officer of PostEra

Why It Matters: This move could not only boost Pfizer's stock but also lead to significant advancements in healthcare treatment and efficiency.

What's Next: Pfizer plans to integrate AI across its drug development pipeline in the coming months. Read More